Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021-Reference-Cited by-同舟云学术

Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021

Published:2024-09-07 Issue:1 Volume:39 Page:
ISSN:1432-1262
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Lin Daopo,Jin Yang,Shao Xiaoxiao,Xu Yuan,Ma Guolong,Jiang Yi,Xu Yinghe,Jiang Yongpo,Hu Dingyuan

Funder

Zhejiang Provincial Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00384-024-04711-x.pdf

Reference25 articles.

1. Kang SG, Gweon TG, Lee HH et al (2022) Reliability and validity of Korean version of crohn’s and ulcerative colitis questionnaire-8. Biomed Res Int 2022(7):9746899

2. Xu YH, Zhu WM, Guo Z (2022) Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease. World J Gastroenterol 28(48):6888–6899

3. GBD 2017 Inflammatory Bowel Disease Collaborators (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5(1):17–30

4. Cantoro L, Monterubbianesi R, Falasco G et al (2023) The earlier you find, the better you treat: red flags for early diagnosis of inflammatory bowel disease. Diagnostics (Basel) 13(20):3183

5. Noble AJ, Nowak JK, Adams AT et al (2023) Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects. Gastroenterology 165(1):44-60.e2